| 2026-10-26 06:13 |
8-K |
["1.01"] |
merger agreement |
0.98
|
Definitive Business Combination Agreement between SPAC Amanat and Corxel Pharmaceuticals with $200M valuation and expected close H1 2027. |
SEC · detail |
| 2026-05-27 17:30 |
8-K |
["8.01", "9.01"] |
other |
0.05
|
IPO closing filing for blank-check SPAC; no M&A signal or transaction disclosed. |
SEC · detail |
| 2026-05-21 09:10 |
8-K |
["1.01", "3.02", "5.02"] |
other |
0.15
|
SPAC IPO filing with standard formation agreements; no M&A transaction indicated yet. |
SEC · detail |